These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 33127426)
21. Effects of formulation and process variables on the aggregation of freeze-dried interleukin-6 (IL-6) after lyophilization and on storage. Lueckel B; Helk B; Bodmer D; Leuenberger H Pharm Dev Technol; 1998 Aug; 3(3):337-46. PubMed ID: 9742554 [TBL] [Abstract][Full Text] [Related]
22. Stability of lyophilized albumin formulations: Role of excipient crystallinity and molecular mobility. Jena S; Krishna Kumar NS; Aksan A; Suryanarayanan R Int J Pharm; 2019 Oct; 569():118568. PubMed ID: 31352055 [TBL] [Abstract][Full Text] [Related]
23. Product and process understanding to relate the effect of freezing method on glycation and aggregation of lyophilized monoclonal antibody formulations. Awotwe-Otoo D; Agarabi C; Read EK; Lute S; Brorson KA; Khan MA Int J Pharm; 2015 Jul; 490(1-2):341-50. PubMed ID: 25835267 [TBL] [Abstract][Full Text] [Related]
24. The ReFOLD assay for protein formulation studies and prediction of protein aggregation during long-term storage. Svilenov H; Winter G Eur J Pharm Biopharm; 2019 Apr; 137():131-139. PubMed ID: 30818009 [TBL] [Abstract][Full Text] [Related]
25. Influence of histidine on the stability and physical properties of a fully human antibody in aqueous and solid forms. Chen B; Bautista R; Yu K; Zapata GA; Mulkerrin MG; Chamow SM Pharm Res; 2003 Dec; 20(12):1952-60. PubMed ID: 14725359 [TBL] [Abstract][Full Text] [Related]
26. Comprehensive evaluation of etanercept stability in various concentrations with biophysical assessment. Kim NA; Lim DG; Lim JY; Kim KH; Jeong SH Int J Pharm; 2014 Jan; 460(1-2):108-18. PubMed ID: 24269208 [TBL] [Abstract][Full Text] [Related]
27. Biophysical characterization and stabilization of the recombinant albumin fusion protein sEphB4-HSA. Shi S; Liu J; Joshi SB; Krasnoperov V; Gill P; Middaugh CR; Volkin DB J Pharm Sci; 2012 Jun; 101(6):1969-84. PubMed ID: 22411527 [TBL] [Abstract][Full Text] [Related]
28. The properties of polyesteramide and the effects on the stability of bovine serum albumin. Ye WP; Xu Y; Du FS Pharm Dev Technol; 1999 Jan; 4(1):97-106. PubMed ID: 10027218 [TBL] [Abstract][Full Text] [Related]
29. Effects of temperature and osmolytes on competing degradation routes for an IgG1 antibody. Roberts CJ; Nesta DP; Kim N J Pharm Sci; 2013 Oct; 102(10):3556-66. PubMed ID: 23873602 [TBL] [Abstract][Full Text] [Related]
30. Selective Stabilization and Destabilization of Protein Domains in Tissue-Type Plasminogen Activator Using Formulation Excipients. Robinson MJ; Matejtschuk P; Longstaff C; Dalby PA Mol Pharm; 2019 Feb; 16(2):744-755. PubMed ID: 30565948 [TBL] [Abstract][Full Text] [Related]
31. Thermally induced conformational changes and protein-protein interactions of bovine serum albumin in aqueous solution under different pH and ionic strengths as revealed by SAXS measurements. Molodenskiy D; Shirshin E; Tikhonova T; Gruzinov A; Peters G; Spinozzi F Phys Chem Chem Phys; 2017 Jul; 19(26):17143-17155. PubMed ID: 28636681 [TBL] [Abstract][Full Text] [Related]
32. Utility of High Throughput Screening Techniques to Predict Stability of Monoclonal Antibody Formulations During Early Stage Development. Goldberg DS; Lewus RA; Esfandiary R; Farkas DC; Mody N; Day KJ; Mallik P; Tracka MB; Sealey SK; Samra HS J Pharm Sci; 2017 Aug; 106(8):1971-1977. PubMed ID: 28456733 [TBL] [Abstract][Full Text] [Related]
33. Optimization of high-concentration endostatin formulation: Harmonization of excipients' contributions on colloidal and conformational stabilities. Wang S; Zhang X; Wu G; Tian Z; Qian F Int J Pharm; 2017 Sep; 530(1-2):173-186. PubMed ID: 28755991 [TBL] [Abstract][Full Text] [Related]
35. Prevention of structural perturbations and aggregation upon encapsulation of bovine serum albumin into poly(lactide-co-glycolide) micropheres using the solid-in-oil-in water technique. Castellanos IJ; Cuadrado WO; Griebenow K J Pharm Pharmacol; 2001 Aug; 53(8):1099-107. PubMed ID: 11518019 [TBL] [Abstract][Full Text] [Related]
36. A comparison of biophysical characterization techniques in predicting monoclonal antibody stability. Thiagarajan G; Semple A; James JK; Cheung JK; Shameem M MAbs; 2016; 8(6):1088-97. PubMed ID: 27210456 [TBL] [Abstract][Full Text] [Related]
37. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions. Bhambhani A; Kissmann JM; Joshi SB; Volkin DB; Kashi RS; Middaugh CR J Pharm Sci; 2012 Mar; 101(3):1120-35. PubMed ID: 22147527 [TBL] [Abstract][Full Text] [Related]
38. Addition of Amino Acids to Further Stabilize Lyophilized Sucrose-Based Protein Formulations: I. Screening of 15 Amino Acids in Two Model Proteins. Forney-Stevens KM; Bogner RH; Pikal MJ J Pharm Sci; 2016 Feb; 105(2):697-704. PubMed ID: 26414114 [TBL] [Abstract][Full Text] [Related]